For in vitro diagnostic use. Nucleus Others Estrogen Receptor SP1 CONFIRM IVD Breast CONFIRM anti-Estrogen Receptor (ER) (SP1) Rabbit Monoclonal Primary Antibody PID00000060 Rabbit SP1 05278406001 CONFIRM ANTI-ER (SP1) CONFIRM anti-Estrogen Receptor (ER) (SP1) Rabbit Monoclonal Primary Anti body 04015630972241 Reagents, kits 790-4324 50 tests Not Available true 05278414001 CONFIRM ANTI-ER (SP1) PRIMARY ANTIBODY CONFIRM anti-Estrogen Receptor (ER) (SP1) Rabbit Monoclonal Primary Anti body 04015630972234 Reagents, kits 790-4325 250 tests Not Available true CONFIRM anti-Estrogen Receptor (ER) (SP1) Rabbit Monoclonal Primary Antibody (CONFIRM anti-ER (SP1) Antikörper) ist für den Laboreinsatz zum qualitativen Nachweis von Estrogenrezeptor (ER)-Antigen in Schnitten von formalinfixiertem, paraffineingebettetem Brustgewebe auf einem VENTANA Färbeautomat mit VENTANA Nachweiskits und Hilfsreagenzien bestimmt. Der CONFIRM anti-ER (SP1) Antikörper ist gegen ein Epitop im Alpha-Protein des humanen ER im Zellkern ER-positiver normaler und neoplastischer Zellen gerichtet. Der CONFIRM anti-ER (SP1) Antikörper ist zur Unterstützung bei der Versorgung, Prognose und Vorhersage des Erfolgs einer Hormontherapie bei Mammakarzinom bestimmt.Dieses Produkt muss von einem qualifizierten Pathologen in Verbindung mit histologischen Untersuchungen, klinisch relevanten Informationen und geeigneten Kontrollen interpretiert werden.Verschreibungspflichtig.Dieser Antikörper ist für die Verwendung in der In-vitro-Diagnostik (IVD) bestimmt. de CONFIRM anti-ER (SP1) antibody binds to ER in formalin-fixed, paraffin-embedded (FFPE) tissue sections. The specific antibody can be localized by either a biotin conjugated secondary antibody formulation that recognizes rabbit immunoglobulins, followed by the addition of a streptavidin horseradish peroxidase (HRP) conjugate (iVIEW DAB Detection Kit) or a secondary antibody-HRP conjugate (ultraView Universal DAB Detection Kit). The specific antibody-enzyme complex is then visualized with a precipitating enzyme reaction product. Clinical cases should be evaluated within the context of the performance of appropriate controls. Ventana recommends the inclusion of a positive tissue control fixed and processed in the same manner as the patient specimen (for example, a weakly positive breast carcinoma or uterus). In addition to staining with CONFIRM anti-ER (SP1) antibody, a second slide should be stained with CONFIRM Negative Control Rabbit Ig. For the test to be considered valid, the positive control tissue should exhibit nuclear staining of the tumor cells or uterine glands and stroma. These components should be negative when stained with CONFIRM Negative Control Rabbit Ig. In addition, it is recommended that a negative tissue control slide (for example, an ER negative breast carcinoma) be included for every batch of samples processed and run on a BenchMark IHC/ISH instrument. This negative tissue control should be stained with CONFIRM anti-ER (SP1) antibody to ensure that the antigen enhancement and other pretreatment procedures did not create false positive staining. en